文献速递脑血管病认知障碍与痴呆

联合神经血管与神经退行性磁共振指标在卒中中的应用

Combining Neurovascular and Neurodegenerative Magnetic Resonance Imaging Measures in Stroke.
PubMed 文献 · Stroke · 2019-01-01

研究基于虚拟国际卒中试验档案-预防子库,纳入317例缺血性卒中或TIA患者,提取白质高信号和脑脊液体积,计算联合体积。联合体积与血管危险因素和认知功能的关联强于单一指标,且可减少临床试验样本量。

要点

  • 联合体积与血管危险因素的关联强于白质高信号或脑脊液体积单独。
  • 联合体积与随访MMSE的关联比白质高信号强32%,比脑脊液体积强12%。
  • 联合体积在临床试验中可减少20%的样本量。

核心结论

  • 联合神经血管与神经退行性磁共振指标(白质高信号和脑脊液体积)比单一指标与血管危险因素和认知功能关联更密切。
  • 联合体积可能成为临床试验中更敏感的测量指标。

研究设计与样本

  • 研究从虚拟国际卒中试验档案-预防子库中提取317例缺血性卒中或短暂性脑缺血发作患者的基线磁共振数据。
  • 对208例有2年随访磁共振的患者评估体积进展,白质高信号和脑脊液体积分别从FLAIR和T1图像分割。
  • 联合指标为白质高信号与脑脊液体积之和经颅内体积标准化。

主要发现

  • 血管危险因素分别解释白质高信号、脑脊液和联合体积变异的7%、11%和12%(均P<0.001)。
  • 基线联合体积与6个月随访MMSE的关联(β=-0.442;SE,0.07;P<0.0001)比白质高信号(β=-0.302;SE,0.06;P<0.0001)强32%,比脑脊液体积(β=-0.391;SE,0.07;P<0.0001)强12%。
  • 联合体积在检测2年体积进展减少10%至40%时,每臂所需患者数比白质高信号单独减少20%至3305例。

临床怎么用

  • 联合神经血管与神经退行性磁共振指标可用于评估卒中患者的血管危险因素和认知功能关联。
  • 在临床试验中,联合体积可能作为更敏感的终点指标,减少样本量需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Individual markers of cerebral small vessel disease and cerebral atrophy explain a small proportion of variance in vascular risk factors and cognitive function. Combining these markers into a single measure of neurovascular and neurodegenerative disease may be more powerful. We assessed this using data contained in the Virtual International Stroke Trials Archive - Prevention sub-archive. Methods- We extracted white matter hyperintensities (WMH) and cerebrospinal fluid (CSF) volumes from 317 people with ischemic stroke or transient ischemic attack who had baseline magnetic resonance imaging. We assessed progression of volumes in 208 people who had 2-year follow-up magnetic resonance imaging. WMH and CSF volumes were segmented from fluid attenuated inversion recovery and T1 images. The combined neurovascular and neurodegenerative measure was the sum of WMH and CSF volume normalized by intracranial volume. We assessed (1) the relationship between baseline vascular risk factors and imaging markers; and (2) the relationship between baseline imaging markers and Mini-Mental State Examination score at follow-up using multiple linear regression. We also assessed implications for sample size calculations using n=208 participants with follow-up magnetic resonance imaging. Results- Vascular risk factors accounted for 7%, 11%, and 12% of the variance in WMH, CSF, and combined volume, respectively (all P<0.001). The association between baseline combined volume and 6-month follow-up Mini-Mental State Examination (β=-0.442; SE, 0.07; P<0.0001) was 32% greater than WMH (β=-0.302; SE, 0.06; P<0.0001) and 12% greater than CSF (β=-0.391; SE, 0.07; P<0.0001) alone. The combined volume required between 207 and 3305 (20%) fewer patients per arm than WMH alone to detect reductions of 10% to 40% in volume progression over 2 years. Conclusions- A combined neurovascular and neurodegenerative magnetic resonance imaging measure including WMH and CSF volume was more closely related to vascular risk factors and cognitive function than either WMH or CSF volume alone. The combined volume may be a more sensitive measurement for clinical trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Wyss A, Dawson J, Arba F, et al. Combining Neurovascular and Neurodegenerative Magnetic Resonance Imaging Measures in Stroke. Stroke. 2019. PMID: 31009345. doi:10.1161/STROKEAHA.118.024181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。